Companies
Zoetis
PharmaceuticalsParsippany, New JerseyZTSAbout 14,500 employees
More about Zoetis
Animal health company that makes medicines, vaccines and diagnostics for pets and livestock
Revenue
$9.5B
Fiscal 2025, up 2.3%
Employees
About 14,500
As of December 2025
Stock
ZTS
New York Stock Exchange
Headquarters
Parsippany, New Jersey
CEO
Kristin Peck
Since January 2020
BrandsSimparica Trio, Apoquel, Cytopoint, Librela, Revolution
Current strategyAdjusting its commercial strategy against new competition, with targeted investment, faster innovation and business development
Recent workforce changes$75M of mainly employee termination costs in Q2 2026 under a cost and productivity program; role count not disclosed
CompetitorsElanco, Merck Animal Health, Boehringer Ingelheim
Related companiesIdexx LaboratoriesMerckPfizer
Checked October 11, 2026 · Sources: sec.gov, sec.gov (2)
Be the first to post about Zoetis
No one has started a discussion here yet. Yours is anonymous and appears right away, and we don’t store who wrote it.
Or follow Zoetis to see the first post in your watchlist.
Follow Zoetis in a feed reader, no account needed: RSS feed